CellPly ^Investors

CellPly is a life-science company that specializes in developing analytical systems for characterizing next-generation cancer immunotherapy. Their main goal is to support the development of novel cancer immunotherapies by accelerating research and development, automating quality control, and advancing the ability to monitor clinical response to these treatments. They achieve this through the use of proprietary microfluidic technologies, highly-automated analytical instruments, and AI-powered image and data analytics. CellPly's products provide unprecedented single-cell analytical solutions, defining the function of the immune system one cell at a time and combining functional data with other multiplex data.